Jen-Wei Tsai

815 total citations
13 papers, 588 citations indexed

About

Jen-Wei Tsai is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Jen-Wei Tsai has authored 13 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Jen-Wei Tsai's work include Sarcoma Diagnosis and Treatment (7 papers), Vascular Tumors and Angiosarcomas (2 papers) and Autophagy in Disease and Therapy (2 papers). Jen-Wei Tsai is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), Vascular Tumors and Angiosarcomas (2 papers) and Autophagy in Disease and Therapy (2 papers). Jen-Wei Tsai collaborates with scholars based in Taiwan, United States and Japan. Jen-Wei Tsai's co-authors include Wei‐Lien Wang, Alexander J. Lazar, Hsuan-Ying Huang, Chien‐Feng Li, Fu-Min Fang, Shih-Chen Yu, Jui Lan, Shau-Hsuan Li, Yu-Hui Wang and Junwen Wang and has published in prestigious journals such as The Journal of Experimental Medicine, Cancer Cell and Clinical Cancer Research.

In The Last Decade

Jen-Wei Tsai

13 papers receiving 584 citations

Peers

Countries citing papers authored by Jen-Wei Tsai

Since Specialization

Citations

This map shows the geographic impact of Jen-Wei Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jen-Wei Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jen-Wei Tsai more than expected).

Fields of papers citing papers by Jen-Wei Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jen-Wei Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jen-Wei Tsai. The network helps show where Jen-Wei Tsai may publish in the future.

Co-authorship network of co-authors of Jen-Wei Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Jen-Wei Tsai. A scholar is included among the top collaborators of Jen-Wei Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jen-Wei Tsai. Jen-Wei Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications 2019 ·Modern Pathology ·Cheng‐Han Lee, Sheng-Yao Su, Kesavan Sittampalam, Paul Chih-Hsueh Chen, Fredrik Petersson, Yu‐Chien Kao, Thomas O. Carpenter, Tsung‐Han Hsieh, Eiichi Konishi, Jen-Wei Tsai, Steven D. Billings, Andrew L. Folpe, Jen‐Chieh Lee	20
2	MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma 2019 ·Cancers ·Anthony P. Conley, Wei‐Lien Wang, J. Andrew Livingston, Vinod Ravi, Jen-Wei Tsai, Ali Ali, Davis R. Ingram, Caitlin D. Lowery, Christina L. Roland, Neeta Somaiah, Patrick Hwu, Cassian Yee, Vivek Subbiah, P. Andrew Futreal, Alexander J. Lazar, Shreyaskumar Patel, Jason Roszik	25
3	Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients 2018 ·Molecular Cancer Therapeutics ·J. Andrew Livingston, Wei‐Lien Wang, Jen-Wei Tsai, Alexander J. Lazar, Cheuk Hong Leung, Heather Lin, Shailesh Advani, Najat C. Daw, (unknown), (unknown), Nancy Gordon, Eugenie S. Kleinerman	15
4	The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma 2018 ·Cancer Cell ·Matthew J. McBride, John L. Pulice, Hannah C. Beird, Davis R. Ingram, (unknown), Jack F. Shern, Gregory W. Charville, Jason L. Hornick, Robert Nakayama, Enrique Garcia-Rivera, Dejka M. Araujo, Wei‐Lien Wang, Jen-Wei Tsai, Michelle Yeagley, Andrew J. Wagner, P. Andrew Futreal, Javed Khan, Alexander J. Lazar, Cigall Kadoch	173
5	Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy 2017 ·Oncotarget ·(unknown), Eugenie S. Kleinerman, (unknown), J. Andrew Livingston, Wei‐Lien Wang, Jen-Wei Tsai, Nancy Gordon	15
6	Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy 2017 ·OncoImmunology ·Emily Z. Keung, Jen-Wei Tsai, (unknown), Janice N. Cormier, Andrew J. Bishop, B. Ashleigh Guadagnolo, Keila E. Torres, Neeta Somaiah, Kelly K. Hunt, Jennifer A. Wargo, Alexander J. Lazar, Wei‐Lien Wang, Christina L. Roland	46
7	Modeling synovial sarcoma metastasis in the mouse: PI3′-lipid signaling and inflammation 2016 ·The Journal of Experimental Medicine ·Jared J. Barrott, Lisa Kafchinski, Huifeng Jin, (unknown), (unknown), Robert J. Kennedy, Tim Mosbruger, Wei‐Lien Wang, Jen-Wei Tsai, Dejka M. Araujo, Ting Liu, Mario R. Capecchi, Alexander J. Lazar, Kevin B. Jones	32
8	Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance 2014 ·Oncotarget ·Chien‐Feng Li, Fu-Min Fang, Hsing-Jien Kung, Li‐Tzong Chen, Junwen Wang, Jen-Wei Tsai, (unknown), Yu-Hui Wang, Shau-Hsuan Li, Hsuan-Ying Huang	19
9	ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance 2013 ·Clinical Cancer Research ·Hsuan-Ying Huang, Wen-Ren Wu, Yu-Hui Wang, Junwen Wang, Fu-Min Fang, Jen-Wei Tsai, Shau-Hsuan Li, (unknown), Shih-Chen Yu, Jui Lan, Yow-Ling Shiue, (unknown), Li‐Tzong Chen, Chien‐Feng Li	118
10	Angiomatoid fibrous histiocytoma: clinicopathological and molecular characterisation with emphasis on variant histomorphology 2013 ·Journal of Clinical Pathology ·Yu‐Chien Kao, Jui Lan, (unknown), Chien‐Feng Li, (unknown), Jen-Wei Tsai, Fu-Min Fang, Shih-Chen Yu, Hsuan-Ying Huang	45
11	Recurrent Amplification at 7q21.2 Targets CDK6 Gene in Primary Myxofibrosarcomas and Identifies CDK6 Overexpression as an Independent Adverse Prognosticator 2012 ·Annals of Surgical Oncology ·Jen-Wei Tsai, Chien‐Feng Li, Yu‐Chien Kao, Junwen Wang, Fu-Min Fang, Yu-Hui Wang, Wen-Ren Wu, Li-Ching Wu, Chung‐Hsi Hsing, Shau-Hsuan Li, Shih-Chen Yu, Jui Lan, Hsuan-Ying Huang	21
12	Id1 promotes lung cancer cell proliferation and tumor growth through Akt-related pathway 2011 ·Cancer Letters ·Yu-Jen Cheng, Jen-Wei Tsai, (unknown), (unknown), Yun‐Ju Chen, (unknown), Shyng‐Shiou F. Yuan	30
13	Combined Erdheim-Chester disease and Langerhans cell histiocytosis of skin are both monoclonal: A rare case with human androgen-receptor gene analysis 2010 ·Journal of the American Academy of Dermatology ·Jen-Wei Tsai, (unknown), Liang‐Yi Hung, (unknown), Kung‐Chao Chang	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact